scPharmaceuticals Inc. (SCPH) Ownership

$3.62

north_east
$0.03 (0.84%)
Day's range
$3.57
Day's range
$3.75

scPharmaceuticals Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ORBIMED ADVISORS LLC 02/14/2025 6.06 M $21.45 M   0.00% 13.01%
RUBRIC CAPITAL MANAGEMENT LP 02/14/2025 4.78 M $16.90 M   0.00% 10.26%
AIGH CAPITAL MANAGEMENT LLC 02/12/2025 4.17 M $14.78 M   1.21% 8.97%
KING LUTHER CAPITAL MANAGEMENT CORP 02/07/2025 2.86 M $10.12 M   28.40% 6.14%
BLACKROCK FUNDING, INC. /DE 02/07/2025 2.28 M $8.08 M   23.17% 4.90%
VANGUARD GROUP INC 02/11/2025 2.11 M $7.46 M   23.38% 4.53%
SUVRETTA CAPITAL MANAGEMENT, LLC 02/14/2025 1.84 M $6.52 M   -10.16% 3.95%
J. GOLDMAN & CO LP 02/14/2025 1.22 M $4.32 M   -11.66% 2.62%
5AM VENTURE MANAGEMENT, LLC 02/14/2025 1.20 M $4.25 M   0.00% 2.58%
UBS GROUP AG 02/14/2025 1.04 M $3.67 M   5,218.29% 2.23%
THRIVENT FINANCIAL FOR LUTHERANS 02/10/2025 1.04 M $3.67 M   -1.17% 2.23%
NANTAHALA CAPITAL MANAGEMENT, LLC 02/14/2025 1.00 M $3.54 M   33.33% 2.15%
RICE HALL JAMES & ASSOCIATES, LLC 01/31/2025 989,635 $3.50 M   59.19% 2.13%
KINGDON CAPITAL MANAGEMENT, L.L.C. 02/14/2025 800,000 $2.83 M   0.00% 1.72%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 750,493 $2.66 M   16.66% 1.61%
STONEPINE CAPITAL MANAGEMENT, LLC 02/14/2025 683,530 $2.42 M   -12.24% 1.47%
TEJARA CAPITAL LTD 02/10/2025 612,850 $2.17 M   -5.75% 1.32%
PERCEPTIVE ADVISORS LLC 02/14/2025 500,000 $1.77 M   100.00% 1.07%
GOLDMAN SACHS GROUP INC 02/11/2025 409,460 $1.45 M   447.63% 0.88%
APIS CAPITAL ADVISORS, LLC 02/14/2025 394,000 $1.39 M   146.25% 0.85%
WOODLINE PARTNERS LP 02/14/2025 297,800 $1.05 M   -40.63% 0.64%
MILLENNIUM MANAGEMENT LLC 02/14/2025 109,909 $389,078   -22.13% 0.24%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 102,854 $364,103   35.53% 0.22%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/14/2025 102,300 $362,142   -26.88% 0.22%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 100,400 $355,416   12.05% 0.22%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 90,503 $320,381   -49.62% 0.19%
RAYMOND JAMES FINANCIAL INC 02/13/2025 89,690 $317,503   100.00% 0.19%
BNP PARIBAS ARBITRAGE, SNC 02/14/2025 85,900 $304,086   1,393.13% 0.18%
JOHNSON FINANCIAL GROUP, LLC 02/04/2025 85,184 $301,551   100.00% 0.18%
JPMORGAN CHASE & CO 02/12/2025 84,827 $300,287   587.30% 0.18%
DEUTSCHE BANK AG\ 02/14/2025 82,488 $292,007   514.48% 0.18%
GROUP ONE TRADING, L.P. 02/14/2025 77,108 $272,962   21.03% 0.17%
BANK OF NEW YORK MELLON CORP 02/04/2025 75,174 $266,116   8.75% 0.16%
BALANCED ROCK INVESTMENT ADVISOR 02/13/2025 70,362 $249,081   8.67% 0.15%
BARCLAYS PLC 02/13/2025 65,361 $232,000   60.81% 0.14%
RHUMBLINE ADVISERS 01/30/2025 42,554 $150,630   20.07% 0.09%
CAPTRUST FINANCIAL ADVISORS 02/14/2025 40,062 $141,819   116.10% 0.09%
COMMONWEALTH EQUITY SERVICES, LLC 02/10/2025 38,771 $137,000   0.00% 0.08%
THOMASVILLE NATIONAL BANK 01/13/2025 37,500 $132,750   0.00% 0.08%
JANE STREET GROUP, LLC 02/14/2025 33,009 $116,852   40.55% 0.07%
CITIGROUP INC 02/12/2025 32,513 $115,097   14.41% 0.07%
INVESCO LTD. 02/13/2025 27,614 $97,754   28.19% 0.06%
XTX TOPCO LTD 02/13/2025 27,531 $97,460   1.33% 0.06%
MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. 02/12/2025 23,471 $84,261   31.58% 0.05%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 02/14/2025 21,973 $77,784   36.09% 0.05%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 21,266 $75,282   13.32% 0.05%
COREBRIDGE FINANCIAL, INC. 02/11/2025 19,586 $69,334   29.03% 0.04%
03/12/2025 19,380 $68,605   100.00% 0.04%
WELLS FARGO & COMPANY/MN 02/13/2025 18,407 $65,161   110.51% 0.04%
ALLIANCEBERNSTEIN L.P. 02/12/2025 15,210 $53,843   0.00% 0.03%

scPharmaceuticals Inc. institutional Ownership - FAQ's

During the previous two years, 106 institutional investors and hedge funds held shares of scPharmaceuticals Inc.. The most heavily invested institutionals were:

ORBIMED ADVISORS LLC: 6.06 M

Rubric Capital Management LP: 4.78 M

AIGH Capital Management LLC: 4.17 M

KING LUTHER CAPITAL MANAGEMENT CORP: 2.86 M

BlackRock Funding, Inc. /DE: 2.28 M

VANGUARD GROUP INC: 2.11 M

85.39% of scPharmaceuticals Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 39.71 M shares in the last 24 months. This purchase volume represents approximately $143.75 M in transactions.